After years of research and clinical testing, we have developed non-invasive, accurate blood tests for early detection of cancer. By making cancer prevention routine, we enable everyone to take control of their own health. The more people take our breakthrough blood tests, the more lives we can save. Life over cancer.
> 4 in 10 people in the U.S. will get cancer in their lifetimes
Cancer continues to be the second leading cause of death in the U.S., and the number of cases of cancer worldwide is projected to increase by 70 percent in the next two decades.
Cancer is catching up with heart disease as #1 cause of death.
Understanding your risk for hereditary cancer is a major step in taking charge of your health.
Up to 20X — Greater lifetime risk of cancer for people who carry specific inherited mutations
Genetic mutations associated with increased hereditary cancer risk are passed from parent to offspring. These inherited abnormal genes are in contrast to acquired mutations which occur after birth and over time, and include environmental factors and lifestyle choices such as smoking or sun exposure.
Individuals who inherit mutated genes associated with cancer not only have a greater risk of getting hereditary cancer, but they also tend to get their cancers earlier in lifetime — and their cancer is usually more aggressive.
9X = Improvement in prognosis when certain cancers are caught in earlier stages
It is well-accepted that the prognosis for cancer survival is highest when detected at early stages. This can be seen when you examine the 5 year survival rate based on stage of detection stage.
For example, for colorectal cancer, stage one detection has more than a 90% survival rate, while stage three and four detection survival rate is as low as 10%. For breast cancer, stage one has almost a 100% survival rate, while stage four cancer has only 22%.
Yet, the majority of patients in majority of cancer cases are detected in late stage. For example fewer than 30 percent of people with cancer in India survive for more than five years after their diagnosis, a sign that cancer is diagnosed only at a later stage.
0 = the number of symptoms of most early stage cancers
Cancer usually strikes without any warning: most early stage cancers show no symptoms at all. In developing countries like India, cancer has already overtaken infectious diseases as a leading cause of death, and the cancer burden is rising dramatically. Think about that.
$100,000 = the average cost of a new cancer drug per patient.
Medical issues are the leading cause of bankruptcies in the U.S., and cost the U.S. healthcare system over $200 billion per year in direct costs and lost productivity. Late stage cancer diagnoses, results in expensive therapies that can have limited on their prognosis, and have a documented detrimental effect on their quality of life.
$299 = The cost for a CellMax Life simple saliva DNA test to learn your risk of hereditary cancer.
CellMax Life offers a simple saliva DNA test for risk of hereditary cancers.
Frequent screening is the best prevention, and it is especially important for people with a higher genetic risk for hereditary cancers. Because there are many types of cancer, and some screening tests can be invasive, by know your risk, you can work with your doctor to tune your health plan.
98 & 25 = the number of genes we examine & the number of hereditary cancers we test for.
One example of the breadth of the hereditary cancer gene panel we analyze is how we assess breast cancer risk. Our CellMax-DNA test covers not only BRCA1 and BRCA2 genes entirely, but it also examines 13 other genes associated with breast cancer: ATM, BARD1, CDH1, CHEK2, NBN, NF1, PALB2, PPM1D, PTEN, RAD51C, RAD51D, STK11, and TP53.